Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Fujian Wanchen Biotechnology Co Ltd
Total Current Assets
Fujian Wanchen Biotechnology Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
Total Current Assets
¥8.9B
|
CAGR 3-Years
217%
|
CAGR 5-Years
149%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Total Current Assets
¥67.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Total Current Assets
¥38B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Total Current Assets
¥140.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Total Current Assets
¥54.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
35%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Total Current Assets
¥29B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
Fujian Wanchen Biotechnology Co Ltd
Glance View
In the coastal province of Fujian, a vibrant ecosystem of innovation thrives with Fujian Wanchen Biotechnology Co. Ltd. at the helm. The company, a beacon of the region's progressive biotech sector, has carved its niche through the development and commercialization of advanced agricultural and health products. At its core, Fujian Wanchen leverages cutting-edge biotechnological research to produce high-quality bio-fertilizers and crop enhancers, addressing the pressing needs of sustainable agriculture. By deploying these organic solutions, it not only fosters healthier crop yields for farmers but also ensures environmental safety, aligning perfectly with global ecological standards. The company stands out in its ability to seamlessly meld technology with traditional agriculture, ensuring that age-old practices are reinforced with modern, efficient solutions. From the fertile fields of Fujian to the bustling trade networks of China and beyond, Fujian Wanchen’s influence extends across significant markets, underpinning its robust revenue streams. The firm earns its profits through a strategic combination of product sales, research partnerships, and licensing of its proprietary technologies. By forging strong alliances with both local and international agricultural entities, it has created a sustainable business model that thrives on innovation and collaboration. The company's expertise in biotechnological applications not only meets the agricultural demand but also ventures into nutraceuticals, offering health supplements that capitalize on the rich biodiversity of the region. This dual focus on agriculture and health positions Fujian Wanchen as a leader in harnessing nature’s potential for both nourishment and prosperity, carving a pathway to a more sustainable future.
See Also
What is Fujian Wanchen Biotechnology Co Ltd's Total Current Assets?
Total Current Assets
8.9B
CNY
Based on the financial report for Dec 31, 2025, Fujian Wanchen Biotechnology Co Ltd's Total Current Assets amounts to 8.9B CNY.
What is Fujian Wanchen Biotechnology Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
149%
Over the last year, the Total Current Assets growth was 54%. The average annual Total Current Assets growth rates for Fujian Wanchen Biotechnology Co Ltd have been 217% over the past three years , 149% over the past five years .